Metformin in Patients With Type 2 Diabetes and Kidney Disease: A Systematic Review
This review nicely summarizes the risks of metformin therapy in patients with mild to moderate chronic kidney disease. According to the authors, there is room for “cautious expansion” of use in this population.
:
Pediatrics: Blood pressure target for renoprotection in children
Perioperative acute kidney injury: risk factors, recognition, management, and outcomes
Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies
Source: Nephrology Now - Category: Urology & Nephrology Authors: Nephrology Now editors Tags: Clinical Nephrology Diabetes Source Type: research
More News: Children | Chronic Kidney Disease | Dementia | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Metformin | Pediatrics | Urology & Nephrology